These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8327334)

  • 1. [The treatment of thyroid diseases using 131I in a special ward with a liquid waste storage plant].
    Wellner U; Schicha H
    Nuklearmedizin; 1993 Jun; 32(3):149-55. PubMed ID: 8327334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
    Wellner U; Eschner W; Hillger HW; Schicha H
    Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of delay tanks in the management of radioactive waste from thyroid therapy.
    Goddard C
    Nucl Med Commun; 1999 Jan; 20(1):85-94. PubMed ID: 9949417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid discharges from patients undergoing 131I treatments.
    Barquero R; Basurto F; Nuñez C; Esteban R
    J Environ Radioact; 2008 Oct; 99(10):1530-4. PubMed ID: 18243440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
    Siekierzyński M
    Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
    Modarresifar H; Almodovar S; Bass WB; Ojha B
    Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation protection during the collection, storage and disposal of 131I-contaminated sewage].
    Unverricht A; Walter W; Gottschild D; Zinner G; Lauterbach H
    Radiobiol Radiother (Berl); 1988; 29(2):217-21. PubMed ID: 3399662
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
    Mattsson S; Johansson L; Jönsson H; Nosslin B
    Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I exhalation by patients undergoing therapy of thyroid diseases.
    Gründel M; Kopka B; Schulz R
    Radiat Prot Dosimetry; 2008; 129(4):435-8. PubMed ID: 17993652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiation of the thyroid during examination of patients with thyroid diseases using radioactive iodine].
    Zvonova IA; Likhtarev AA; Nikolaeva AA
    Med Radiol (Mosk); 1984 Feb; 29(2):42-4. PubMed ID: 6700389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation protection recommendations as applied to the disposal of long-lived solid radioactive waste. A report of The International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(4):i-vii, 1-25. PubMed ID: 10860107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.
    Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R
    Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus proposal on the use of 131I in the treatment of thyrotoxicosis and thyroid cancer].
    Michaud P
    Rev Med Chil; 1998 Jul; 126(7):855-65. PubMed ID: 9830780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].
    Krohn T; Meyer PT; Ocklenburg C; Knollmann D; Nowak B; Schaefer WM
    Nuklearmedizin; 2008; 47(6):248-54. PubMed ID: 19057798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
    Stabin MG
    J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the post-therapeutic dosimetry of patients with short-term hospitalization after 131I therapy sufficiently reliable?].
    Körber C; Schneider P; Hänscheid H; Köck PR; Reiners C
    Nuklearmedizin; 2000; 39(1):9-12. PubMed ID: 10726251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new proposal for monitoring patients in nuclear medicine.
    Willegaignon J; Guimarães MI; Sapienza MT; Stabin MG; Malvestiti LF; Marone M; Sordi GM
    Health Phys; 2006 Dec; 91(6):624-9. PubMed ID: 17099406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioactivity in municipal sewage and sludge.
    Martin JE; Fenner FD
    Public Health Rep; 1997; 112(4):308-16; discussion 317-8. PubMed ID: 9258296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.